MedPath
FDA Approval

Fosfomycin Tromethamine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Zambon USA, Ltd
DUNS: 118086168
Effective Date
October 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fosfomycin(3 g in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Zambon Switzerland Ltd

Zambon USA, Ltd

481761344

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fosfomycin Tromethamine

Product Details

NDC Product Code
82036-4274
Application Number
NDA050717
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
October 3, 2023
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
SACCHARINInactive
Code: FST467XS7DClass: IACT
Code: 7FXW6U30GYClass: ACTIMQuantity: 3 g in 1 1
TANGERINEInactive
Code: KH3E3096OOClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
© Copyright 2025. All Rights Reserved by MedPath